S8-2 "Points to consider" regarding the safety assessment of biotechnology-derived pharmaceuticals in non-clinical studies(SYMPOSIUM 8: TOXICOLOGICAL EVALUATION OF BIOLOGICAL AGENTS)(Proceedings of the 31st Annual Meeting)

スポンサーリンク

概要

• 論文の詳細を見る
• 日本トキシコロジー学会の論文
• 2004-10-29

著者

• Nakazawa Takahiro

  Pharmaceutical Research Laboratories Eli Lilly Japan

関連論文

• S8-2 "Points to consider" regarding the safety assessment of biotechnology-derived pharmaceuticals in non-clinical studies(SYMPOSIUM 8: TOXICOLOGICAL EVALUATION OF BIOLOGICAL AGENTS)(Proceedings of the 31st Annual Meeting)

スポンサーリンク